Fundraising Fox
/Companies
Sign in

Freenome

NASDAQ: FRNM

London, US · Founded 2015 · United Kingdom corporation · 410 employees on LinkedIn · 22 known investors

Find your way into Freenome

821 people in our graph can introduce you to the Freenome team.

Sign up to see every warm intro you have to Freenome

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Freenome team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Freenome was founded in 2015 by Riley Ennis, Charles Roberts, and Gabriel Otte.

RERiley Ennis
Riley EnnisFounderRiley Ennis co-founded Freenome, which develops blood-based cancer detection technology. Previously, he founded Immudicon/Oncolinx, a biotech company focused on immuno-oncology biologics targeting dendritic cell delivery and tumor microenvironment mechanisms, which partnered with multiple pharmaceutical companies.
CR
Charles RobertsFounder
GOGabriel Otte
Gabriel OtteCEO, Co-founder2016–2021
AS
Adam StoneChief Executive Officer and Director
MA
Michael AltmanChief Business Officer and Director
S(
Shmuel (Sam) M. CohnChief Financial Officer
AE
Aaron Elliott, Ph.D.Chief Executive Officer
CR
Charlie RobertsFounder
MMMichael Ma
Michael MaFounderPartner at Liquid Ventures

Board

SL
Stuart LawsonBoard director

Investors · 22

Agent Capitallisted by Agent CapitalWaltham

How we know: Agent Capital's portfolio page · the VCSheet dataset · Not right? Tell us

AME Cloud Ventureslisted by AME Cloud VenturesPalo Alto · $1M – $10M

How we know: AME Cloud Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Andreessen Horowitzlisted by Andreessen HorowitzMenlo Park · $500K – $50M

How we know: a16z's portfolio · company funding news (hacker news) · medium.com · open dataset · 5k.vc investor directory · Not right? Tell us

Artis Ventureslisted by Artis VenturesSan Francisco · $50K – $25M

How we know: Artis Ventures's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Asset Management Companylisted by Asset Management CompanyMenlo Park · $500K – $2M

How we know: Asset Management Company's portfolio page · Not right? Tell us

Averin Capitallisted by Averin CapitalNew York

How we know: Averin Capital's portfolio page · Not right? Tell us

Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston

How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us

Catalio Capital Management, LPlisted by Catalio Capital Management, LPNew York

How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us

CRV (Charles River Ventures)listed by CRV (Charles River Ventures)Bay Area · $250K – $5M

How we know: CRV (Charles River Ventures)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

EcoR1 Capitallisted by EcoR1 CapitalSan Francisco
GV (Google Ventures)listed by GV (Google Ventures)Mountain View · $250K – $50M

How we know: GV (Google Ventures)'s portfolio page · company funding news (hacker news) · medium.com · open dataset · 5k.vc investor directory · Not right? Tell us

HBM Healthcare Investmentslisted by HBM Healthcare InvestmentsZug

How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us

HBM Partnerslisted by HBM PartnersZug · $5M – $50M

How we know: HBM Partners's portfolio page · Not right? Tell us

Intermountain Healthlisted by Intermountain Health
Kaiser Permanente Ventureslisted by Kaiser Permanente VenturesSan Francisco · $2M – $5M

How we know: Kaiser Permanente Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Ridgeback Capitallisted by Ridgeback CapitalNew York

How we know: Ridgeback Capital's portfolio page · Not right? Tell us

Roche Venture Fundlisted by Roche Venture FundBasel · $648K – $3.2M

How we know: Roche Venture Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

StartXlisted by StartXStanford · $10K – $1M

How we know: StartX's portfolio page · Not right? Tell us

BrightEdgereportedAtlanta

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Polaris PartnersreportedBoston · $500K – $5M

How we know: a partner's Signal profile · Not right? Tell us

Funding

SEC filings, press & company announcements

$800K disclosed across 1 of 2 rounds · 2015–2017

▶$800KraisedOct 2015 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stuart LawsonDirector
  • Charles RobertsDirector
  • Gabriel OtteDirector
Offering amount
$800K
Amount sold
$800K
First sale
Oct 2015
Incorporated
Corporation, United Kingdom, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

The Freenome mafia →

13 people who came through Freenome went on to found or lead other companies.

Amir NashatBoard MemberFounded Jnana Therapeutics +3Michael MaFounderFounded Liquid2 +1Nick MarkInvestor and AdvisorFounded Culmination BioDaniel DelubacVP, Laboratory Technologies and OperationsFounded iOrganBioJonathan HirschAdvisor, Real World Evidence & Data PlatformFounded SynapticureJay ChiaML Infrastructure EngineerFounded EventualAbhinav GopalSoftware EngineerFounded RubbrbandDavid WeinbergPrincipal ScientistFounded ParcelBioDima VremenkoSoftware Engineer InternFounded InkboxJay ChiaMachine Learning Platform EngineerFounded EventualLance BaldoChief Medical OfficerFounded BeacontxScott FergusonSenior Research ScientistFounded Kascaid

+ 1 more →

Related companies · 10

ImmunomeImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.
MyomeMyOme provides genomic insights and clinical genetic screening reports to help individuals and healthcare providers assess risks for hereditary conditions and make informed health decisions.
Alterome Therapeutics, Inc.Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic. It focuses on hard-to-drug cancer targets such as mutant KRAS and mutant AKT E17K across malignancies including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancers.
CellanomeCellanome develops a live-cell analysis platform using CellCage technology to create controlled microenvironments that enable researchers to observe cell behavior and molecular changes over time. The platform generates structured multimodal data for life sciences researchers and biopharma companies focused on oncology, neuroscience, immunology, and aging research.
Noveome BiotherapeuticsNoveome is a clinical-stage biopharmaceutical company developing ST266, a multi-targeted secretome containing hundreds of biologically active proteins designed for neuroprotection, inflammation modulation, and tissue healing. The company is investigating ST266's potential across ophthalmology, neurology, dermatology, and other therapeutic areas.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
MetronomeMetronome provides a usage-based billing platform for SaaS companies, enabling them to launch products faster and make data-driven revenue decisions. The platform handles billing operations at scale, allowing companies to iterate pricing strategies and connect billing to product experiences.
healthOmeHealthŌme combines insurance with health navigation services to improve how patients access, finance, and receive precision healthcare.
NucleomeNucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.
Zip DrugZipdrug is a prescription delivery and pharmacy benefit platform, acquired by Anthem's PBM IngenioRx in 2020.

Companies working in the same space as Freenome.

Frequently asked questions

What does Freenome do?
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
Who founded Freenome?
Freenome was founded by Riley Ennis, Charles Roberts, Gabriel Otte in 2015.
Who are Freenome's investors?
Freenome's investors include RA Capital, Agent Capital, AME Cloud Ventures, Andreessen Horowitz, Artis Ventures, Asset Management Company, Averin Capital, Bain Capital Life Sciences and 14 more.
How much funding has Freenome raised?
Freenome has disclosed $800K raised across 1 of its 2 known rounds.
Where is Freenome headquartered?
Freenome is headquartered in London, US.